C

Catalyst Pharmaceuticals
D

CPRX

21.410
USD
0.29
(1.37%)
Market Open
Volume
17,476
EPS
2
Div Yield
-
P/E
18
Market Cap
2,553,644,265
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ANIP
    -2.440
    (-4.14%)
    56.560 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    E
    ERYP
    -0.02670
    (-3.45%)
    0.70000 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    K
    KPTI
    -0.02960
    (-3.54%)
    0.80740 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    More
News

Title: Catalyst Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.